Work

Ab0445 Characteristics of First-line Upadacitinib Initiators and Factors Contributing to Prescribing Upadacitinib as First-line B/tsdmard

Year: 2023

Type: conference-abstract

Source: Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2023-eular.3284

Authors: W. Krueger, L. Harrold, A. Sima, T. Eckmann, R. Kilpatrick

Institutions: AbbVie (United States), University of Massachusetts Chan Medical School

Language: English

Topic: Rheumatoid Arthritis Research and Therapies

Subfield: Rheumatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

Funder: Bristol-Myers Squibb

OpenAlex ID: W4379648564

Cites:

Cited by:

Related to: 10